Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, SMS Pharmaceuticals has informed that it attached the transcript of the Conference Call held on Friday, 10th November, 2023 for the second quarter and half year ended 30th September, 2023. A copy of the said Transcript is being uploaded on the website of the Company www.smspharma.com.
The above information is a part of company’s filings submitted to BSE.